Angiotensin converting enzyme and neprilysin inhibition alter pain response in dexhamethasone-induced hypertensive rats-Reference-Cited by-同舟云学术

Angiotensin converting enzyme and neprilysin inhibition alter pain response in dexhamethasone-induced hypertensive rats

Published:2019-04 Issue:2 Volume:71 Page:306-310
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacological Reports

Author:

Aykan Duygun Altıntaş^ORCID,Koca Tuba Tulay^ORCID,Yaman Selma,Eser Nadire

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Reference30 articles.

1. Dissociation of hypertension and enhanced clonidine-induced antinociception in spontaneously hypertensive rats;Lin;Pain,1993

2. Hypertension-associated hypalgesia. Evidence in experimental animals and humans, pathophysiological mechanisms, and potential clinical consequences;Ghione;Hypertension,1996

3. Spinal nociceptive transmission in the spontaneously hypertensive and Wistar-Kyoto normotensive rat;Randich;Pain,1994

4. Relationship between increased blood pressure and hypoalgesia: additional evidence for the existence of an abnormality of pain perception in arterial hypertension in humans;Rosa;J Hum Hypertens,1994

5. Naloxone reverses the antinociceptive action of clonidine in spontaneously hypertensive rats;Tchakarov;Brain Res,1985

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current understanding of the link between angiotensin-converting enzyme and pain perception;Drug Discovery Today;2024-09

2. A structure-based pharmacophore modelling approach to identify and design new neprilysin (NEP) inhibitors: An in silico-based investigation;Archives of Biochemistry and Biophysics;2024-06

3. From the PnTx2-6 Toxin to the PnPP-19 Engineered Peptide: Therapeutic Potential in Erectile Dysfunction, Nociception, and Glaucoma;Frontiers in Molecular Biosciences;2022-04-11

4. Angiotensin receptor-neprilysin inhibition by sacubitril/valsartan attenuates doxorubicin-induced cardiotoxicity in a pretreatment mice model by interfering with oxidative stress, inflammation, and Caspase 3 apoptotic pathway;The Anatolian Journal of Cardiology;2021-11-05

5. Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study;Journal of Molecular Structure;2021-01